nktr-262
Showing 1 - 1 of 1
Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer Trial in United States (NKTR-262, bempegaldesleukin, nivolumab)
Terminated
- Melanoma
- +6 more
- NKTR-262
- +2 more
-
Scottsdale, Arizona
- +13 more
Jun 24, 2022